Prospective observational study on the effect of metronidazole gel 0.75% "Maruishi" on quality of life

Prospective observational study on the effect of metronidazole gel 0.75% "Maruishi" on quality of life - Prospective observational study on the effect of metronidazole gel 0.75% "Maruishi" on quality of life

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000059335

Enrollment

Registered

2025-10-10

Start date

2025-10-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancerous skin ulcer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Individuals aged 18 years or older at the time consent is obtained 2. Individuals who, after receiving sufficient explanation regarding participation in this study, provided informed consent based on full understanding and of their own free will 3. Patients with cancerous skin ulcers with a life expectancy of 3 months or longer 4. Patients prescribed Metronidazole Gel 0.75% Maruishi

Exclusion criteria

Exclusion criteria: 1. Patients who have used metronidazole 0.75% gel, metronidazole ointment, or other metronidazole products within the past week 2. Patients with a history of hypersensitivity to any component of this drug 3. Patients with organic brain or spinal cord disease (excluding patients with brain or spinal cord tumors) 4. Women within the first three months of pregnancy 5. Patients unable to read or write Japanese due to cognitive impairment, visual impairment, or other reasons 6. Other patients deemed unsuitable as study subjects by the principal investigator

Design outcomes

Primary

Measure	Time frame
Change from baseline in DLQI score at day 15	—

Secondary

Measure	Time frame
Odor score on the 15th day, usability survey, adverse events	—

Countries

Japan

Contacts

Public ContactAkira Takahashi

National Cancer Center Hospital East Department of Dermatologic Oncology

atakahas@east.ncc.go.jp04-7133-1111

Outcome results